Skip to main content
U2BIO CO., LTD. logo

U2BIO CO., LTD. — Investor Relations & Filings

Ticker · 221800 ISIN · KR7221800006 KO Human health and social work activities
Open in API
Filings indexed 227 across all filing types
Latest filing 2019-03-29 Annual Report
Country KR South Korea
Listing KO 221800

About U2BIO CO., LTD.

https://www.u2bio.co.kr/eng/main.do

U2BIO CO., LTD. is a healthcare technology company specializing in the integration of biotechnology (BT) and information technology (IT). The company provides a range of in vitro diagnostic services, including clinical laboratory tests and molecular diagnostics. Concurrently, it develops and offers digital healthcare solutions and medical IT services tailored for medical institutions such as hospitals and clinics. U2BIO focuses on delivering personalized healthcare services based on scientific data to support medical professionals and improve patient health outcomes.

Recent filings

Filing Released Lang Actions
사업보고서 (2018.12)
Annual Report Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for the company 'U2Bio' (주식회사 유투바이오) for the fiscal year ending December 31, 2018. It includes the independent auditor's report, financial statements (Balance Sheet, Income Statement, Statement of Changes in Equity, Cash Flow Statement), and detailed notes to the financial statements. This constitutes a full annual financial report, which falls under the 'Annual Report' (10-K) category in the provided schema, as it contains the comprehensive financial performance and audit results for the full fiscal year. FY 2018
2019-03-29 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회 결과' (Annual General Meeting Results) and provides a detailed breakdown of the voting outcomes for various agenda items (financial statement approval, director appointments, remuneration limits) at the company's AGM held on 2019-03-27. This fits the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2019-03-27 Korean
감사보고서제출
Audit Report / Information Classification · 98% confidence The document is titled '감사보고서 제출' (Submission of Audit Report) and provides a summary of the audit opinion and key financial data (assets, liabilities, revenue, etc.) as of March 15, 2019. While it contains financial data, it is a formal notification of the submission of the audit report to the regulatory body rather than the full annual report itself. According to the 'Menu vs Meal' rule, this is a report publication announcement. FY 2018
2019-03-15 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for U2Bio. It contains the meeting agenda, date, location, and detailed management reports (business overview, industry status, and financial information) required for shareholder review prior to the meeting. This document is a standard proxy statement/notice package provided to shareholders to inform them of the upcoming AGM and the matters to be voted upon.
2019-03-12 Korean
주주총회집중일개최사유신고
Regulatory Filings Classification · 95% confidence The document is a formal regulatory filing submitted to the Korea Exchange (KRX) regarding the 'Reason for holding a General Meeting of Shareholders on a concentrated date'. It explains why the company, U2Bio, is holding its shareholder meeting on a date that coincides with the 'concentrated' dates identified by the exchange. This is a specific regulatory disclosure requirement for Korean listed companies and does not fit into categories like AGM-R (presentation materials) or PSI (proxy solicitation). It is a regulatory announcement regarding corporate governance scheduling, thus falling under RNS.
2019-03-12 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집 결의) for the company U2Bio. It outlines the date, location, and agenda items (financial statement approval, director appointments, and remuneration limits). This document is a standard proxy solicitation material used to inform shareholders of an upcoming meeting and the matters to be voted upon, which fits the definition of a Proxy Solicitation & Information Statement.
2019-03-08 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.